EZH2 and rectal neoplasm: SDR16C5 has been found to be upregulated in KRAS-mutant rectal tumors compared to KRAS wild-type [37], and increased SIRPA may be indirectly linked to mutant KRAS through the overexpression of the EZH2 polycomb complex [46].